课题基金 / 基金详情

Gene expression in programmed cell death

Gene expression in programmed cell death
程序性细胞死亡中的基因表达
批准号:
RGPIN-2019-06034
负责人:
Bell, Brendan
金额:
$3.64万
依托单位:
依托单位国家:
加拿大
项目类别:
Discovery Grants Program - Individual
财政年份:
2022
资助国家:
加拿大
项目状态:
已结题
起止时间:
2022-01-01 至 2023-12-31

项目摘要

项目成果

Bell, Brendan的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The normal development and survival of animals require that some of their cells undergo a form of cellular suicide, termed programmed cell death. For example, during development, fingers are formed when the cells between the fingers die via programmed cell death. The Bell laboratory has discovered and continues to lead investigations into a new pathway of programmed cell death, termed the TAF6delta  pathway. The TAF6delta  pathway differs from known pathways of cell death in several important respects. These include its ability to kill cells in the absence of a central suicide protein known as p53, and, more importantly, the fact that the gene that encodes TAF6 is essential to cell survival, whereas those of other known cell death proteins are not. Here, we propose a research program to better understand how cells are able to interpret their environment to decide whether to undergo suicide or continue to live, using the TAF6 pathway as a model. We propose to answer three research questions. 1) Firstly, we know TAF6 is cleaved by cellular enzymes during cell death. We will ask whether or not this cleavage functions to accelerate or potentially slow down the cell death process. 2) Secondly, we will dissect the molecular responsible for turning on the TAF6delta  pathway. We will identify cellular proteins that control TAF6delta  expression using a powerful analytical technique called mass spectrometry. 3) Thirdly, we will determine where in the body TAF6delta  is expressed, using both experimental and computational methods. The outcome of our research will be to shed further light on the TAF6delta  pathway and its impact on cell death. Better understanding cell death pathways has far-reaching applications in biomedicine and biotechnology. Concretely, several disease states, including neurodegenerative disorders such as Alzheimer's disease and cancer, result from uncontrolled cell death. Moreover, the control of cell death has potential applications in ecology, agriculture and the food industry to increase or decrease biomass. Importantly, our research program provides a multidisciplinary, inclusive and collaborative environment for the training of the next generation of young scientists. By providing deeper insights into programmed cell, and by creating training opportunities for young researchers, our research program will contribute to a dynamic Canadian knowledge-based economy.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Gene expression in programmed cell death
  • 批准号:
    RGPIN-2019-06034
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $3.64万
  • 财政年份:
    2021
  • 负责人:
    Bell, Brendan
  • 依托单位:
Gene expression in programmed cell death
  • 批准号:
    RGPIN-2019-06034
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $3.64万
  • 财政年份:
    2020
  • 负责人:
    Bell, Brendan
  • 依托单位:
Gene expression in programmed cell death
  • 批准号:
    RGPIN-2019-06034
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $3.64万
  • 财政年份:
    2019
  • 负责人:
    Bell, Brendan
  • 依托单位:
Gene expression in programmed cell death
  • 批准号:
    RGPIN-2014-04271
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $2.55万
  • 财政年份:
    2018
  • 负责人:
    Bell, Brendan
  • 依托单位:
国内基金
海外基金
缺氧诱导因子(HIF)-2α转录抑制树突状细胞CD36表达减轻肾脏缺血再灌注损伤的机制
  • 批准号:
    82370751
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    张明
  • 依托单位:
内源性蛋白酶抑制剂SerpinA3N对缺血性脑卒中后血脑屏障的保护作用及其表达调控机制
  • 批准号:
    82371317
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    万杰清
  • 依托单位:
基于FCER1G基因介导免疫反应探讨迟发性聋与认知障碍相关性的机制研究
  • 批准号:
    82371141
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    陈颖
  • 依托单位:
22q11.2染色体微重复影响TOP3B表达并导致腭裂发生的机制研究
  • 批准号:
    82370906
  • 项目类别:
    面上项目
  • 资助金额:
    48.00万元
  • 批准年份:
    2023
  • 负责人:
    代杰文
  • 依托单位: